In addition to its role in cancer and CVD, MALAT1 is also significantly up-regulated in diabetic gastroparesis (DGP) (Gong et al., 2018), which is a clinically relevant complication of diabetes mellitus characterized by bloating, nausea and vomiting (Kashyap and Farrugia, 2010). Here, MALAT1 is linked to cancer.